The enhancer where rs2472632 is located is predicted to target the CCDC34 gene, an oncogene that has been reported to be up-regulated in bladder cancer [29], cervical cancer [30], colorectal cancer [31], and PDAC [32]. The gene discussed is CCDC34; the disease is urinary bladder cancer.